Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1994 3
1996 1
1997 3
1999 2
2000 2
2001 4
2002 2
2003 2
2004 2
2005 1
2006 3
2010 1
2011 3
2012 2
2013 2
2014 6
2015 6
2016 5
2017 5
2018 1
2019 5
2020 7
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Standardized classification and reporting of glomerulonephritis.
Sethi S, Fervenza FC. Sethi S, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220. Nephrol Dial Transplant. 2019. PMID: 30124958 Review.
A kidney biopsy is done to determine the etiology of the glomerulonephritis (GN) and the severity of the lesion, to identify whether other lesions, related to or not related to the GN, are present on the kidney biopsy and finally to ascertain the extent of chronicity of th …
A kidney biopsy is done to determine the etiology of the glomerulonephritis (GN) and the severity of the lesion, to identify whether …
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC. Lafayette RA, et al. J Am Soc Nephrol. 2017 Apr;28(4):1306-1313. doi: 10.1681/ASN.2016060640. Epub 2016 Nov 7. J Am Soc Nephrol. 2017. PMID: 27821627 Free PMC article. Clinical Trial.
IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of immunosuppressive agents added to standard therapy, several recent studies have questioned efficacy of these agents. ...Lack of efficacy of rituximab, at least at this stage and …
IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of immunosuppressive agents added to stan …
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.
Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC. Sethi S, et al. J Am Soc Nephrol. 2016 May;27(5):1278-87. doi: 10.1681/ASN.2015060612. Epub 2015 Nov 13. J Am Soc Nephrol. 2016. PMID: 26567243 Free PMC article.
The primary diagnosis should include the disease entity/pathogenic type (if disease entity is not known) followed in order by pattern of injury (mixed patterns may be present); score/grade/class for disease entities, such as IgA nephropathy, lupus nephritis, and ANC …
The primary diagnosis should include the disease entity/pathogenic type (if disease entity is not known) followed in order by pattern of inj …
The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.
Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, Sethi S, Leung N, Fervenza FC, Cornell LD. Nasr SH, et al. Kidney Int. 2016 Apr;89(4):897-908. doi: 10.1016/j.kint.2016.02.001. Kidney Int. 2016. PMID: 26994577 Free article.
Classic anti-glomerular basement membrane (GBM) disease presents with rapidly progressive glomerulonephritis (GN) with or without pulmonary hemorrhage. On biopsy typical disease displays bright polytypic linear GBM staining for IgG by immunofluorescence and diffuse crescen …
Classic anti-glomerular basement membrane (GBM) disease presents with rapidly progressive glomerulonephritis (GN) with or without pul …
ADAM10 mediates ectopic proximal tubule development and renal fibrosis through Notch signalling.
Li B, Zhu C, Dong L, Qin J, Xiang W, Davidson AJ, Feng S, Wang Y, Shen X, Weng C, Wang C, Zhu T, Teng L, Wang J, Englert C, Chen J, Jiang H. Li B, et al. J Pathol. 2020 Nov;252(3):274-289. doi: 10.1002/path.5517. Epub 2020 Sep 24. J Pathol. 2020. PMID: 32715474 Free PMC article.
Finally, both ADAM10 and NOTCH2 expression were positively correlated with the degree of renal interstitial fibrosis in IgA nephropathy patients, and increased ADAM10 expression was negatively correlated with decreased kidney function evaluated by serum creatinine, …
Finally, both ADAM10 and NOTCH2 expression were positively correlated with the degree of renal interstitial fibrosis in IgA nephro …
Elderly patients with glomerular diseases and IgA nephropathy.
Lin J, Cheng Z, Qian Q. Lin J, et al. Nephrology (Carlton). 2017 Dec;22 Suppl 4:20-26. doi: 10.1111/nep.13144. Nephrology (Carlton). 2017. PMID: 29155502 Review.
In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney biopsy in elderly patients, as well as treatment strategies and precautions. We also review the available data on IgA nephropathy …
In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney …
IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease.
Nasr SH, D'Agati VD. Nasr SH, et al. Nephron Clin Pract. 2011;119(1):c18-25; discussion c26. doi: 10.1159/000324180. Epub 2011 Jun 9. Nephron Clin Pract. 2011. PMID: 21659781 Free article. Review.
IgA-dominant acute postinfectious glomerulonephritis (APIGN) is an increasingly recognized morphologic variant of APIGN, particularly in the elderly. ...The pathogenetic mechanism of selective IgA deposition in patients with poststaphylococcal glomerulonep …
IgA-dominant acute postinfectious glomerulonephritis (APIGN) is an increasingly recognized morphologic variant of APIGN, parti …
IgG4-related kidney disease.
Cornell LD. Cornell LD. Semin Diagn Pathol. 2012 Nov;29(4):245-50. doi: 10.1053/j.semdp.2012.07.004. Semin Diagn Pathol. 2012. PMID: 23068304 Review.
Glomeruli may be affected by IgG4-RD, usually in the form of membranous glomerulonephritis. Other patterns of glomerular disease include IgA nephropathy, membranoproliferative glomerulonephritis, and endocapillary or mesangioproliferative immune comple …
Glomeruli may be affected by IgG4-RD, usually in the form of membranous glomerulonephritis. Other patterns of glomerular disease incl …
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
Dillon JJ. Dillon JJ. Semin Nephrol. 2004 May;24(3):218-24. doi: 10.1016/j.semnephrol.2004.01.003. Semin Nephrol. 2004. PMID: 15156527 Review.
Among patients with IgA nephropathy, both ACE inhibitors and ARBs reduce the transglomerular passage of large, but not small, molecules, reducing proteinuria. ...There is no reason to believe that this information is not applicable to IgA nephropathy. …
Among patients with IgA nephropathy, both ACE inhibitors and ARBs reduce the transglomerular passage of large, but not small, …
Thin basement membrane nephropathy associated with other glomerular diseases.
Norby SM, Cosio FG. Norby SM, et al. Semin Nephrol. 2005 May;25(3):176-9. doi: 10.1016/j.semnephrol.2005.01.010. Semin Nephrol. 2005. PMID: 15880329 Review.
Many reports confirm that thin basement membrane nephropathy (TBMN) commonly occurs together with other glomerular diseases such as minimal change glomerulonephritis, diabetes, membranous nephropathy, immunoglobulin (Ig)A glomerulonephritis, and focal …
Many reports confirm that thin basement membrane nephropathy (TBMN) commonly occurs together with other glomerular diseases such as m …
72 results